Cargando…
The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target
Despite ongoing efforts, a highly effective vaccine against Plasmodium falciparum remains elusive. Vaccines targeting the pre-erythrocytic stages of the P. falciparum life cycle are the most advanced to date, affording moderate levels of efficacy in field trials. However, the discovery that the memb...
Autores principales: | Ragotte, Robert J., Higgins, Matthew K., Draper, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246332/ https://www.ncbi.nlm.nih.gov/pubmed/32359873 http://dx.doi.org/10.1016/j.pt.2020.04.003 |
Ejemplares similares
-
Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites
por: Knuepfer, Ellen, et al.
Publicado: (2019) -
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
por: Healer, Julie, et al.
Publicado: (2022) -
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes
por: Healer, Julie, et al.
Publicado: (2019) -
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinations
por: Azasi, Yvonne, et al.
Publicado: (2020) -
Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies
por: Nacer, Adéla, et al.
Publicado: (2022)